Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib with Docetaxel and Carboplatin in NSCLC
NCT00687297Phase 2Completed
- Sponsor
- PrECOG
- Start
- Apr 2008
- Primary completion
- Jan 2011
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vandetanib in non-small cell lung cancer (NSCLC), sponsored by PrECOG. Started Apr 2008; status: completed.
02
Drugs
vandetanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00687297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687297.